A multicentre, randomised, double-blind, controlled, parallel group study to evaulate the efficacy and safety of different concentrations of FK778 with tacrolimus (FK506) and steroids versus a standard regimen of tacrolimus, MMF [mycophenolate mofetil] and steroids in renal transplant patients
Latest Information Update: 03 Nov 2021
At a glance
- Drugs FK 778 (Primary) ; Corticosteroids; Mycophenolate mofetil; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 09 Mar 2010 Additional lead trial investigator [Neumayer HH] identified as reported by ClinicalTrials.gov.
- 05 Dec 2005 New trial record.